Exchange Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$658K Buy
23,066
+46
+0.2% +$1.22K 0.41% 68
2026
Q2
$554K Sell
23,020
-2,262
-9% -$59.2K 0.35% 80
2026
Q1
$710K Hold
25,282
– – 0.49% 64
2025
Q4
$630K Sell
25,282
-2,022
-7% -$51K 0.44% 68
2025
Q3
$696K Buy
27,304
+6,399
+31% +$158K 0.48% 61
2025
Q2
$507K Sell
20,905
-3,014
-13% -$70.3K 0.4% 75
2025
Q1
$606K Sell
23,919
-188
-0.8% -$4.92K 0.49% 59
2024
Q4
$640K Buy
24,107
+214
+0.9% +$5.8K 0.51% 59
2024
Q3
$691K Hold
23,893
– – 0.57% 52
2024
Q2
$669K Sell
23,893
-1,177
-5% -$32.4K 0.57% 51
2024
Q1
$696K Sell
25,070
-3,170
-11% -$88K 0.57% 50
2023
Q4
$813K Sell
28,240
-2,033
-7% -$61.5K 0.7% 41
2023
Q3
$1M Sell
30,273
-300
-1% -$10.6K 0.96% 31
2023
Q2
$1.12M Buy
+30,573
New +$1.19M 1.08% 29

Other funds holding PFE

Exchange Bank's PFE Position: Q3 2026 in Review

Exchange Bank increased its Pfizer (PFE) stake by 0.2% in Q3 2026, buying an estimated $1.22K and bringing the position to 23,066 shares worth $658K. The position accounts for 0.41% of the portfolio, ranked #68.

Exchange Bank first reported a position in PFE in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.12M in Q2 2023. 881 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Exchange Bank held 23,066 shares of Pfizer worth $658K as of Q3 2026.
  • Exchange Bank bought 46 Pfizer shares in Q3 2026, an estimated $1.22K.
  • Pfizer made up 0.41% of Exchange Bank's portfolio in Q3 2026, its #68 holding.
  • Exchange Bank first reported a position in Pfizer in Q2 2023 and has held it in 14 quarters since.
  • Exchange Bank's Pfizer position peaked at $1.12M in Q2 2023.
  • 881 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Exchange Bank's 13F filing for Q3 2026, filed 7 Oct 2026.